Cell Therapy Takes Aim at Rare Nerve Tumors in New Preclinical Breakthrough
Researchers have developed an optimized tumor-infiltrating lymphocyte manufacturing protocol that shows preclinical efficacy against NF1- and schwannomatosis-related nerve sheath tumors, ...
